Purchase Order 75D30122P15680
Award Date
9/23/22
Potential Completion Date
9/29/23
Potential Value
$77K
Federal Agency
CDC Pittsburgh
Awardee
Clear Labs Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Carlos, CA 94070, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, is for COVID-19 genomic sequencing services and related products. The $403,128.72 firm-fixed-price delivery order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 and has an ultimate completion date of September 30, 2025. Additionally, Clear Labs holds a $16 million single-award indefinite delivery contract (IDV) with the VA Veterans...
This $4,500 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company specializing in COVID-19 genomic sequencing services and related products. The contract is for the LYVE system relocation, with a completion date of May 27, 2024. Clear Labs has also received several other federal contracts and sub-awards from agencies like the Department of Veterans Affairs, National...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,950 firm-fixed-price purchase order to Clear Labs Inc., a for-profit manufacturer, to provide the CLEAR DX INSTRUMENT. This award is not associated with a set-aside program. Clear Labs Inc. has previously received prime federal contracts from the Department of Veterans Affairs and Department of Health and Human Services to provide COVID-19 genomic sequencing services, reagents, and...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Clear Labs Inc. to provide a CLEAR DX Instrument for COVID-19 testing and sequencing. The $232,327.60 contract was awarded on March 16, 2021 and has a completion date of April 14, 2022. This contract is not designated as a set-aside. Clear Labs Inc. is a for-profit manufacturer that has previously provided COVID-19 genomic sequencing services, reagents, and instrumentation...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $467,144.72 firm-fixed-price delivery order contract to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, to provide COVID-19 genomic sequencing services and associated products. The contract runs through September 30, 2024, and is not designated as a set-aside. Clear Labs specializes in indexing the global food supply, setting standards for food integrity, and providing COVID-19 genomic...
Clear Labs Inc. was awarded a $259,184.24 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 for genomic sequencing services. The delivery order was issued against Clear Labs' indefinite delivery contract with the VA worth up to $16 million for COVID-19 genomic sequencing and related supplies from October 2022 through September 2027. Under this task order, Clear Labs will provide sequencing reagents,...
This federal contract award, valued at $2,957,000.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company. The contract is for the development of in vitro diagnostics for biodefense, antimicrobial resistant infections, and emerging infectious diseases, as part of NIAID's Broad Agency Announcement BAA2023-1. This is a definitive contract with a cost-no-fee pricing type, and the period of...
The Department of Veterans Affairs Veterans Health Administration awarded a $109,947.20 firm-fixed-price purchase order to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, to provide maintenance services for their CLEAR DX instrument system. This purchase order is part of a larger $16 million indefinite delivery contract awarded to Clear Labs in October 2022 to provide COVID-19 genomic sequencing services and associated products to the VA through September 2027. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $625,064 firm fixed price purchase order to Clear Labs Inc. to provide COVID-19 genomic sequencing reagents for the Clear Labs DX analyzer. The place of performance for supplying these reagents is Palo Alto, California. The period of performance is from May 12, 2022 to September 30, 2022. This contract will facilitate VA's genomic sequencing efforts to support veterans' healthcare...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...